LCQ-908 - CAS 956136-95-1
Catalog number:
956136-95-1
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H24F3N3O2
Molecular Weight:
455.47
COA:
Inquire
Targets:
DGAT
Description:
LCQ-908 is a new generation of diacylglycerol acyltransferase 1 (DGAT1) inhibitor as anti-obesity and anti-diabetic agents. It is now in phase II clinical trials.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Pradigastat
MSDS:
Inquire
1.DGAT1 inhibitors as anti-obesity and anti-diabetic agents.
Birch AM1, Buckett LK, Turnbull AV. Curr Opin Drug Discov Devel. 2010 Jul;13(4):489-96.
Since 2008, significant advances have been made in understanding the role of diacylglycerol acyl transferase-1 (DGAT1) in disease states such as diabetes and obesity. Gene deletion and overexpression studies have provided important new insights into the function of DGAT1, as have the first reports from preclinical models of small-molecule inhibitor effects, which are discussed in this review in relation to the phenotypes of DGAT knockout and overexpression models. The progress of medicinal chemistry efforts has resulted in a new generation of DGAT1 inhibitors that have progressed into clinical development, with the leading compound LCQ-908 (Novartis AG) now in phase II clinical trials. This exciting progress has led researchers to anticipate that an understanding of the human pharmacology of DGAT1 inhibitors, as well as their potential as therapeutic agents for the treatment of diabetes and obesity, will be achieved in the next few years.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related DGAT Products


CAS 701232-20-4 T863

T863
(CAS: 701232-20-4)

T-863 is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGA...

CAS 828934-41-4 (R)-((addition))-Etomoxir sodium salt

(R)-((addition))-Etomoxir sodium salt
(CAS: 828934-41-4)

(R)-((addition))-Etomoxir sodium salt is a potent inhibitor of carnitine palmitoyltransferase I (CPT1), which inhibits β-oxidation in mitochondria. It has shown...

PF-06424439
(CAS: 1469284-78-3)

PF-06424439, a imidazo-pyridin derivative, has been found to be a selective DGAT2 inhibitor that could be probably effective against dyslipidemic rodent in anim...

CAS 1166827-44-6 AZD7687

AZD7687
(CAS: 1166827-44-6)

AZD7687 is a potent and selective DGAT1 inhibitor with an IC50 value of 80 nM (hDGAT1).

CAS 1031336-60-3 ABT-046

ABT-046
(CAS: 1031336-60-3)

ABT-046 is a potent, selective, and orally bioavailable Diacylglycerol acyltransferase 1 (DGAT-1 ) inhibitor (IC50=8 nM).

CAS 1449779-49-0 DGAT1-IN-1

DGAT1-IN-1
(CAS: 1449779-49-0)

Imidazopyridine and imidazothiazole compounds as inhibitors of diacylglycerol o-acyltransferase type 1 enzyme and their preparation.

CAS 124083-20-1 Etomoxir

Etomoxir
(CAS: 124083-20-1)

An inhibitor of carnitine palmitoyltransferase A (CPT1), which is required for the oexidation of long-chain acyl CoA esters. A strong inhibitor of mitochondrial...

CAS 956136-95-1 LCQ-908

LCQ-908
(CAS: 956136-95-1)

LCQ-908 is a new generation of diacylglycerol acyltransferase 1 (DGAT1) inhibitor as anti-obesity and anti-diabetic agents. It is now in phase II clinical trial...

CAS 942999-61-3 DGAT-1 inhibitor 2

DGAT-1 inhibitor 2
(CAS: 942999-61-3)

DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1, which is one of two known DGAT enzymes that catalyze the final step in triglyceride synthesis. It is a p...

CAS 959122-11-3 A922500

A922500
(CAS: 959122-11-3)

A922500 is an inhibitor for human and mouse DGAT-1 with IC50 of 7 nM and 24 nM, respectively, good selectivity over related acyltransferases, hERG, and a panel ...

CAS 1109276-89-2 PF-04620110

PF-04620110
(CAS: 1109276-89-2)

PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.

Chemical Structure

CAS 956136-95-1 LCQ-908

Quick Inquiry

Verification code

Featured Items